Safety and Efficacy Study in the Treatment of Intestinal Problems Associated With Autism
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00110708|
Recruitment Status : Unknown
Verified February 2006 by PediaMed Pharmaceuticals.
Recruitment status was: Active, not recruiting
First Posted : May 13, 2005
Last Update Posted : February 22, 2006
Information provided by:
No Study Results Posted on ClinicalTrials.gov for this Study
|Recruitment Status :||Unknown|
|Primary Completion Date :||No date given|
|Estimated Study Completion Date :||June 2006|
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Handen BL, Melmed RD, Hansen RL, Aman MG, Burnham DL, Bruss JB, McDougle CJ. A double-blind, placebo-controlled trial of oral human immunoglobulin for gastrointestinal dysfunction in children with autistic disorder. J Autism Dev Disord. 2009 May;39(5):796-805. doi: 10.1007/s10803-008-0687-y. Epub 2009 Jan 16.